Trials / Completed
CompletedNCT03609385
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 254 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of the PRAISE study is to develop a diagnostic algorithm that allows the prediction of acute coronary syndrome in stroke patients with elevated levels of cardiac troponin.
Detailed description
Elevation of cardiac troponin can be found in about 30% of patients with acute ischemic stroke (depending on the assay used). Elevated troponin indicates increased mortality in stroke patients. There is currently little evidence regarding the ideal care of these patients. The investigators know from previous studies that approximately 25% of acute stroke patients with elevated levels of cardiac troponin have culprit lesions on coronary angiogram. The primary goal of the PRAISE study is to develop a diagnostic algorithm that allows the prediction of acute coronary syndrome in stroke patients. To achieve this, clinical symptoms, troponin levels as well as findings on EKG, echocardiography and coronary angiography will be systematically evaluated. The PRAISE study is a multicenter study with more than 20 sites in Germany. Joint funding will be provided by DZHK (German center of cardiovascular research) und DZNE (German center of neurodegenerative diseases). Acute ischaemic stroke patients with elevated troponin are eligible for participation in the study. The primary endpoint is the diagnosis of acute coronary syndrome as established by an independent endpoint committee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Coronary angiography | In patients eligible for participation in the study coronary angiography, echocardiography and EKG will be performed systematically. |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2021-12-20
- Completion
- 2022-09-26
- First posted
- 2018-08-01
- Last updated
- 2025-03-26
- Results posted
- 2025-03-26
Locations
28 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03609385. Inclusion in this directory is not an endorsement.